Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CATX · NYSE · Pharmaceutical Preparations
Perspective Therapeutics (CATX) · oqro.io/stocks/CATX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.9431+0.1007 (+11.95%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 12, 2026 · Filed Nov 13, 2026
Officer purchased ~$30K of CATX shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
Officer purchased ~$5K of CATX shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 12, 2026
CEO purchased ~$38K of CATX shares in the open marketSource5%+ stake, activist · Stake as of Nov 10, 2026 · Filed Nov 12, 2026
Lantheus Holdings, Inc. cut its CATX stake below 5% (3.9%)SourceInsider trade · Traded Mar 28, 2025 · Filed Apr 1, 2025
CFO purchased ~$75K of CATX shares in the open marketSourceInsider trade · Traded Mar 28, 2025 · Filed Apr 1, 2025
CEO purchased ~$49K of CATX shares in the open marketSourceInsider trade · Traded Mar 31, 2025 · Filed Apr 1, 2025
Director purchased ~$82K of CATX shares in the open marketSourceInsider trade · Traded Mar 28, 2025 · Filed Apr 1, 2025
Director purchased ~$50K of CATX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP no longer reported CATX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deerfield Management Company, L.P. disclosed an increased position in CATX for Q4 2024SourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
Director purchased ~$100K of CATX shares in the open marketSourceInsider trade · Traded Dec 4, 2024 · Filed Dec 4, 2024
CEO purchased ~$30K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CFO purchased ~$39K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CFO purchased ~$8.6K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CFO purchased ~$1.4K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
CFO purchased ~$114 of CATX shares in the open marketSourceInsider trade · Traded Mar 31, 2025 · Filed Apr 1, 2025
Director purchased ~$50K of CATX shares in the open marketSourceInsider trade · Traded Mar 28, 2025 · Filed Apr 1, 2025
CEO purchased ~$10K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
Director purchased ~$13K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 27, 2024
Director purchased ~$9.6K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 26, 2024
CEO purchased ~$55K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 26, 2024
CEO purchased ~$25K of CATX shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 26, 2024
CEO purchased ~$21K of CATX shares in the open marketSource